Masayo Takahashi

External Member
KOBE CITY EYE HOSPITAL

The team is developing transplantation therapy using human iPS-derived retinal tissues (retinal pigment epithelium and photoreceptors) and gene therapy for the treatment of retinal degeneration diseases. To do so, they are improving the quality and culture methods of iPS cells and retinal organoids. Additionally, in order to constantly supply high-quality cells, which are currently produced by a handful of experienced researchers, a new technology is now being developed by combining the general-purpose humanoid robot, “Maholo”, and AI.